CN109394869A - Pu Rongshuan creams and preparation method thereof - Google Patents
Pu Rongshuan creams and preparation method thereof Download PDFInfo
- Publication number
- CN109394869A CN109394869A CN201811552156.5A CN201811552156A CN109394869A CN 109394869 A CN109394869 A CN 109394869A CN 201811552156 A CN201811552156 A CN 201811552156A CN 109394869 A CN109394869 A CN 109394869A
- Authority
- CN
- China
- Prior art keywords
- rongshuan
- creams
- parts
- preparation
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims description 31
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 29
- 241000167550 Centella Species 0.000 claims abstract description 26
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 25
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 24
- 239000001771 mentha piperita Substances 0.000 claims abstract description 23
- 238000001704 evaporation Methods 0.000 claims abstract description 7
- 230000008020 evaporation Effects 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 35
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 26
- 241000245665 Taraxacum Species 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 19
- 235000013871 bee wax Nutrition 0.000 claims description 18
- 239000012166 beeswax Substances 0.000 claims description 18
- 239000006210 lotion Substances 0.000 claims description 18
- 235000010489 acacia gum Nutrition 0.000 claims description 17
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 17
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims description 16
- 239000010495 camellia oil Substances 0.000 claims description 16
- 235000019441 ethanol Nutrition 0.000 claims description 16
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims description 16
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims description 16
- 239000004166 Lanolin Substances 0.000 claims description 14
- 235000019388 lanolin Nutrition 0.000 claims description 14
- 229940039717 lanolin Drugs 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 235000011449 Rosa Nutrition 0.000 claims description 9
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 230000004927 fusion Effects 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims 1
- 210000002268 wool Anatomy 0.000 claims 1
- 235000005206 Hibiscus Nutrition 0.000 abstract description 21
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 abstract description 21
- 235000003973 Hibiscus mutabilis Nutrition 0.000 abstract description 21
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract description 21
- 240000001949 Taraxacum officinale Species 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 32
- 230000000694 effects Effects 0.000 description 29
- 208000002193 Pain Diseases 0.000 description 25
- 230000036407 pain Effects 0.000 description 24
- 239000003814 drug Substances 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 235000019580 granularity Nutrition 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 244000246386 Mentha pulegium Species 0.000 description 5
- 235000016257 Mentha pulegium Nutrition 0.000 description 5
- 235000004357 Mentha x piperita Nutrition 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 235000001050 hortel pimenta Nutrition 0.000 description 5
- 210000005075 mammary gland Anatomy 0.000 description 5
- 208000004396 mastitis Diseases 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 230000003285 pharmacodynamic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000034656 Contusions Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 208000034526 bruise Diseases 0.000 description 4
- 239000008845 cholagoga Substances 0.000 description 4
- 229940124571 cholagogue Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000001114 myogenic effect Effects 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 208000024818 Nipple disease Diseases 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 208000001786 gonorrhea Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 239000001674 (E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BGTBFNDXYDYBEY-UHFFFAOYSA-N 1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one Chemical compound CC=CC(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010034016 Paronychia Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000003260 anti-sepsis Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- -1 catechu naphthols Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 206010024378 leukocytosis Diseases 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 229930007790 rose oxide Natural products 0.000 description 2
- 230000008470 skin growth Effects 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000005223 Alkalosis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001115458 Carphophis Species 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011684 Cutaneous tuberculosis Diseases 0.000 description 1
- RDFLLVCQYHQOBU-GPGGJFNDSA-O Cyanin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@H](CO)O1)c1c(-c2cc(O)c(O)cc2)[o+]c2c(c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)cc(O)c2)c1 RDFLLVCQYHQOBU-GPGGJFNDSA-O 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 1
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029421 Nipple pain Diseases 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000012642 Sexual Trauma Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 230000002340 alkalosis Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229930185884 camellianin Natural products 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- RDFLLVCQYHQOBU-ZOTFFYTFSA-O cyanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=C(O)C(O)=CC=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 RDFLLVCQYHQOBU-ZOTFFYTFSA-O 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Pu Rongshuan creams, with dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella etc. for raw material, emulsify and are prepared after extracted, purifying, evaporation and concentration.Beneficial effects of the present invention: raw material of the present invention is fresh raw material, including fresh dandelion, fresh cottonrose hibiscus leaf, fresh oldenlandia diffusa, fresh dried peppermint leaf and fresh centella, the effective component in raw material is remained to greatest extent, the loss for causing effective component because being dried to dry raw material is prevented, therapeutic effect is influenced.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of Pu Rongshuan creams and preparation method thereof.
Background technique
Mammary gland is to belong to sexual organ, tissue by ovary estrogen and progestogen influenced and the physiological hyperplasia of generating period and
It restores, the cell hyperplasia of breast duct, leaflet or its surrounding connective tissue is then caused when meromorphosis, be referred to as mammary gland and increase
Raw disease (selecting from nineteen ninety-five, " TCM theory of cyclomastopathy " in " Journal of Traditional Chinese Medicine " of the 8th phase).The proliferation of mammary gland is clinical
Common disease, frequently-occurring disease, it is in rising trend in recent years.Every value is premenstrual or menstrual period breast make it is swollen, even turgor pain, or itches with nipple
Pain person, referred to as " distending pain of breasts during menstruation ".To occur swollen breasts in the last fortnight as cardinal symptom, severe one may occur in which this disease feature
Breast fullness has agglomeration, and symptom can periodically occur repeatedly.It is clinically to think that this disease and endocrine disturbance and mental element pierce more
Swash related (selecting from 2017, " treatment cyclomastopathy clinical observation " in " world's traditional Chinese medicine " of A01 phase).
In the prior art, it mostly uses dry powder or dry plate to fill raw material and carries out preparation creams, if carrying out preparation cream with fresh feed
Frost, is all made of the principle of now-making-now-using, but looks for fresh feed hardly possible, make trouble, is inconvenient to use, cannot store mutability for a long time
Matter.
Summary of the invention
It is of the existing technology in order to solve the problems, such as, the present invention provides a kind of Pu Rongshuan creams and preparation method thereof,
Overcome the fresh green herbal medicine of existing system and now do and now apply, manufactured lotion be easy to air-dry it is rotten, the shortcomings that cannot storing for a long time;The present invention
Pu Rongshuan creams be the milk knot that rises to adult female breast cyclomastopathy, mazoitis, cracked nipple, nursing breast distending pain
Block, skin wounds dampen swelling etc. and hurt the traditional Chinese medicine for outer use creams that disease has obvious curative effects, it is easier to store and patient is facilitated to make
With.
The object of the present invention is to provide a kind of Pu Rongshuan creams.
Another object of the present invention is to provide the preparation method of above-mentioned Pu Rongshuan creams.
The Pu Rongshuan creams of specific embodiment according to the present invention, the Pu Rongshuan creams are prepared by following raw material, institute
Stating raw material by weight includes: 12-16 parts of dandelion;8-12 parts of cottonrose hibiscus leaf;6-10 parts of oldenlandia diffusa;3-5 parts of dried peppermint leaf;
3-5 parts and Rosmarinic acid 0.6-1.0 parts of centella.
The Pu Rongshuan creams of specific embodiment according to the present invention, wherein the raw material include by camellia oil, beeswax,
The substrate material of lanolin and Arabic gum composition, the substrate material includes: 1-3 parts of camellia oil by weight;6-9 parts of beeswax;Sheep
4.0-4.5 parts of rouge of hair;4.0-4.5 parts of Arabic gum.
The Pu Rongshuan creams of specific embodiment according to the present invention, further, the Pu Rongshuan creams are by following original
Material preparation, the raw material includes: 14 parts of dandelion by weight;10 parts of cottonrose hibiscus leaf;8 parts of oldenlandia diffusa;4 parts of dried peppermint leaf;
4 parts of centella;0.8 part of Rosmarinic acid;2 parts of camellia oil;7.5 parts of beeswax;4.25 parts of lanolin;4.25 parts of Arabic gum.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, the described method comprises the following steps:
(1) it is cut after fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella being removed impurity respectively
It is broken, it is mixed to form mixture, the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, pure water is added and is mentioned
It takes, forms extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by macroreticular resin, then is washed using ethyl alcohol
It is de-, obtain refined solution;
(3) refined solution that step (2) obtains is evaporated concentration, obtained and mixture etc. described in step (1)
The medicinal extract extracting solution of weight;
(4) after addition Rosmarinic acid is mixed into the medicinal extract extracting solution that step (3) obtains, pure water is added,
It is steam heated to 75-85 DEG C after mixing, is added in substrate material and is uniformly mixed, Rosa Damascana is then added, is uniformly mixed,
It is cooled into liquid lotion;
(5) the liquid lotion for obtaining step (4) emulsifies, then carries out being ground to fine-micron level degree, sterilizing
Afterwards up to the Pu Rongshuan creams.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein in step (4), the base
Material the preparation method comprises the following steps: weigh camellia oil, beeswax, lanolin and Arabic gum according to the ratio, be steam heated to after mixing completely
It is soluble and fused, is subsequently cooled to 75-85 DEG C, constant temperature is spare after filtering.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein described to be steam heated to 110
DEG C, substrate material is completely dissolved fusion, is subsequently cooled to 80 DEG C, and constant temperature is spare at 80 DEG C after filtering.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein described mixed in step (1)
The total amount of adding for closing material is the 40% of the Pu Rongshuan creams weight;In step (4), the total amount of adding of the substrate material is described
The 18% of Pu Rongshuan creams weight.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein described to mention in step (1)
Pure water is first added before taking and did not had mixture 1-2cm, impregnates 30 minutes, the mixture is then put into continuous flow upstream ultrasound and is followed
In ring extractor, adds pure water and extract;The total amount of adding of the pure water and the weight ratio of mixture are 240:
40;The temperature of the extraction is 60 DEG C, and the time of the extraction is 1 hour.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein described big in step (2)
Hole resin is LSA-21 macroreticular resin, and the ethyl alcohol is food grade ethyl alcohol.Macroporous absorbent resin be it is a kind of without cation exchange groups and
There is the preparation of macroporous structure, there is good macroreticular structure and biggish specific surface area, there can be selection
Ground passes through the organic matter in physical absorption aqueous solution.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein in step (3), the steaming
The temperature of hair concentration is 100 DEG C, and the time of the evaporation and concentration is 120 minutes.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein in step (4), be added to
It is 80 revs/min by revolving speed in substrate material be thoroughly mixed 40 minutes, Rosa Damascana is then added, it is small continues stirring 1
Shi Zhizhi is uniformly mixed.
The preparation method of the Pu Rongshuan creams of specific embodiment according to the present invention, wherein described to grind in step (5)
Mill uses colloid mill to be ground to fine granularity as 260 mesh, specifically: the liquid lotion is ground by 200 mesh fine granularities first, then is divided
5 circulating reflux millizations;260 mesh fine granularities finally are arranged in colloidal mill, all cremes are ground, up to the Pu after sterilizing
Rong feels well creams.
The sterilizing is using ultraviolet disinfection 4 hour, then is passed through ozone sterilization 8 hours, then to the refreshing cream of the Pu Rong
It is aseptic subpackaged by clean automatic air pressure filling machine progress that frost standing is placed on the workshop GMP for 24 hours.
The application method of Pu Rongshuan creams of the invention is applied 2 times a day according to affected part size and is smeared, and thickness is no more than
The Pu Rongshuan creams of the invention of 0.5mm clean after each chrisma creams half an hour.
Dandelion, dandelion herb be rich in vitamin A, vitamin C and potassium, also containing iron, calcium, vitamin B2, vitamin B1,
Magnesium, vitamin B6, folic acid and copper.Specific constituent content is mainly moisture, every 60 grams of dandelion herb leaves moisture content 86%, albumen
1.6 grams of matter, 5.3 grams of carbohydrate, there are about 108.8 kilojoules for heat.Contain taraxol, dandelion in dandelion plant
A variety of health-nutrition ingredients such as element, choline, organic acid, synanthrin.Nature and flavor are sweet, slight bitter, tremble with fear.Return liver, stomach meridian.There is diuresis, laxative, move back
Jaundice, cholagogue and other effects.It is swollen to control heat toxin, carbuncle swells, sore, internal carbuncle, red eye, swell pain, damp and hot, jaundice, the puckery pain of dribbling urination, furunculosis
Poison, acute mastitis, scrofula, toothache, hot eyes, pharyngalgia, pulmonary abscess, acute appendicitis, jaundice with damp-heat pathogen, puckery pain of heat gonorrhea.Control acute mastitis, lymph gland
Inflammation, scrofula, boil poisonous soreness, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, gall-bladder
Inflammation, urinary tract infections etc..Anti-inflammation detumescence pharmacodynamic raw materials compatibility is used as in the present invention.Dandelion is that clinic important simply commonly uses medium-height grass
The effect of medicine integrates medicinal and edible, Ju You Cheongju thermal detoxification, dispersing swelling and dissipating binds and inducing diuresis for treating strangurtia.Clinically it is mainly used for controlling
Treat the diseases such as acute mastitis, scrofula, furuncle swelling toxin, pharyngalgia, pulmonary abscess, acute appendicitis, hot eyes, jaundice with damp-heat pathogen, puckery pain of heat gonorrhea.Pharmacological testing shows
Dandelion has broad-spectrum antiseptic, Hepatoprotective cholagogue, antiendotoxin, stomach invigorating and immunologic enhancement.
Cottonrose hibiscus leaf, acrid flavour are mild-natured;Return lung, Liver Channel;With cool blood, detoxify, the effect of detumescence, analgesic.For ulcer larynx
Swollen, be burdened with She Dan, scald, red eye, swell pain, traumatic injury.Anti-inflammation detumescence pharmacodynamic raw materials compatibility is used as in the present invention.
Oldenlandia diffusa, it is bitter, light, it is cold in nature.Primary efficacy is clearing heat and detoxicating, medicinal powder for relieving pain knot, promoting urination and removing dampness.Cure mainly lung heat
It breathes with cough, abscess of throat, acute appendicitis, furuncle sore, venomous snake bite, puckery pain of heat gonorrhea, oedema, dysentery, enteritis, jaundice with damp-heat pathogen, You Shanzhi
Treat various types inflammation and cancerous swelling;Immunity can be enhanced, there is tumor suppression, inhibit production of sperm, antivenomous effect.Make in the present invention
For medicinal powder for relieving pain knot pharmacodynamic raw materials compatibility.Oldenlandia diffusa contains a variety of chemical components such as Anthraquinones, flavonoids, terpene, has and exempts from
Epidemic disease adjusts, is antitumor, anti-oxidant, anti-chemical mutagenesis, anti-inflammatory, antibacterial, Hepatoprotective cholagogue, analgesia removing toxic substances and other effects.
Dried peppermint leaf can improve sense Mao fever, throat, swelling and pain, and eliminate head with stomach invigorating wind-dispelling, eliminating the phlegm, cholagogue, anti-spasm
Bitterly, toothache, nausea sense.It is also commonly used for production cooking or dessert, to remove fish and mutton fishy smell, or collocation fruit and dessert, is used
To render palatable;It may be alternatively configured the lotion of anti-inflammation detumescence.Refrigerant throat-moistening specific to peppermint and the pleasant smell of fragrance covering up and
Improve some senses of discomfort that there is peculiar smell and be difficult to the drug swallowed.Peppermint Water topical application has refrigerant, antipruritic, anti-inflammatory, analgesic
The effect of.Menthol can stimulate cutaneous nerve tip receptor, first generate cool feeling, then there is slight burning heat sensation.Slowly
In the saturating fell in ground, cause prolonged hyperemia, and reaches therapeutic effect;Antipyretic: a small amount of peppermint energy stimulating central nervous systems make surrounding
Telangiectasis and radiate;And promote sweat gland secretion and sweating.Therefore there is the hypothermic effect of drop;It is anti-inflammatory: 8 contained by peppermint
Kind of catechu naphthols acid is effective anti-inflammatory agent, can inhibit mono- hydroxysteroid dehydrogenase of 3a and have weak from anti-inflammatory effect.Contained by peppermint
Blue sesame oil hydrocarbon have anti-inflammatory effect to Scalded Rabbits ear.It is used as analgesic, antipyretic, anti-inflammation detumescence pharmacodynamic raw materials compatibility in the present invention,
Also antisepsis is played.
Centella, all herbal medicine, clearing heat and promoting diuresis, subdhing swelling and detoxicating, control acute diseases such as cholera and sunstroke xenon abdominal pain, heat rushes down, dysentery, jaundice with damp-heat pathogen, sand leaching,
Blood strangury is spat, blood, hemoptysis, hot eyes, larynx are swollen, rubeola, scabies, malignant boil carbuncle swells poison, traumatic injury etc..Inhibit proliferation of fibrous tissue: accumulated snow
Careless glycosides can inhibit collagenous fibres, have the function of inhibiting proliferation of fibrous tissue.Promote skin growth: it is raw that rabbit intramuscular injection can promote skin
Long, local leukocytosis, connective tissue rete vasculosum increases, and mucilage secretion increases, and fur hyperplasia accelerates, and has and skin is inhibited to burst
The effect of ulcer;The stable effect of calmness: centella glucoside contained therein has calm, stable effect to mouse, rat, this effect is main
It is the influence of the cholinergic system in Central nervous system.Alcohol extracting thing is without analgesic activity;Effect to skin histology: accumulated snow
Careless glucoside can treat skin ulcer, such as obstinate sexual trauma, cutaneous tuberculosis, leprosy;Mouse, cavy, rabbit muscle are injected or subcutaneous
Implantation can promote skin growth, local leukocytosis, connective tissue rete vasculosum hyperplasia, mucous secretion increase, the life of hair and tail
Long acceleration etc.;Clearing heat and promoting diuresis: treatment abscess of throat, aphthae, headache, body heat are thirsty etc.;Activating microcirculation and removing stasis medicinal: swollen for bruise
Bitterly, worm snake bite, redness and swelling of joints etc.;Antibacterial anti-inflammatory: shingles zoster caused by treating because of virus or bacterium, dysentery, damp and hot Huang
Subcutaneous ulcer, oedema, stranguria.It can also be used for erysipelas, scrofula, close pyogenic infections from tumour or sore;Li Shui and spleen: treatment is because of watery diarrhea caused by damp and hot, dysentery, also
For gasteremphraxis have a stomachache, stomach Qi not under, indigestion, gasteremphraxis hiccup, children's infantile malnutrition symptom;Anastalsis: hematuria, bleeding from five sense organs or subcutaneous tissue, pain are used for
Through various bleedings such as, metrorrhagia and metrostaxis, hematochezia, hemorrhoid hemorrhage, gastrorrhagia, traumatic hemorrhage, there is hemostasis and pain-relieving;Improve memory:
Modern medical research has found that centella really has the effect of promoting memory, rosemary also has similar effect, hears one often
Essential oil made of rosemary is heard, brain stress hormone cortisol is adjusted, you is allowed to keep awake the moment;Other effects: alcohol extracting
Object can relax isolated rat ileum, and glucoside part can reduce the tension and shrinkage amplitude of rabbit and isolated rat ileum, and can be slight
Inhibit the effect of acetylcholine.To anesthetized dog, intravenous injection can slight excited breathing, heart rate is slack-off and moderate reduces blood pressure,
The latter two cannot have been reported that asiaticoside has therapeutic effect to leprosy by That atropine blocks.In the present invention as detumescence, inhibition
Hyperplasia pharmacodynamic raw materials compatibility.
Rosmarinic acid, has a stronger anti-inflammatory activity, while Rosmarinic acid also has anti-oxidant, antibacterial, antiviral, anti-swollen
The activity of tumor.Also there is antidepression and the stabilization to color, to the inhibiting effect of hyaluronidase, to xanthine oxidase
Inhibiting effect, liver protection effect, inhibit angiogenesis function, prevent artery sclerosis from acting on, prevent memory impairment etc..In the present invention
Middle preservative anti-oxidant, antibacterial as medicinal extract liquid.
Camellia oil, the fatty acid contained have 5 palmitinic acid, stearic acid, arachidic acid, oleic acid and linoleic acid (C18:2) components,
Wherein oleic acid and linoleic acid account for 76.79%.Also contain camellianin, tea polyphenols, saponin, tannin, and is rich in antioxidant and has
The squalene of anti-inflammatory effect, squalene and Flavonoid substances play the role of anticancer splendid.Camellia oil is also rich in vitamin E
With the microelements such as calcium, iron, zinc.Immune, anti anoxia and antifatigue, low-temperature resistance stress, lipid peroxidation inhibition, anti-with bidirectional modulation
Mutagenesis has the effects of adjusting, kidney tonifying thrombus dissolving to kidney.The tea polyphenols wherein contained have anti-aging, it is anti-radiation, to cancer cell
Inhibition, antibacterial, sterilization, the inhibiting effect to AIDS virus, to the anti-Xie Zuoyong of heavy metallic salt and biological alkalosis;Protect tooth
Improving eyesight and the effect for removing halitosis;Digestion-aid effect;Enhance capilary obdurability, reducing blood lipid, prevents liver and coronary artery congee
Sample hardening;Blood pressure lowering, it is hypoglycemic, prevent headstroke, antithrombotic, antiallergic action and cutaneous anaphylaxis, stomach of releiving it is nervous,
Anti- inflammation antidiarrheal and diuresis, the absorption for promoting Vc, prevention and treatment scurvy;Absorption of the human body to iron is improved, anaemia is effectively prevent.Have
Help inhibit cardiovascular disease, beauty and skin care, arousing brain, raising spirit, diuresis is recovered from fatigue, lipid-loweringing is aid digestion, reduce cholesterol, pre- preventing tumor.
In the present invention as reparation one of skin drug effect compatibility and emulsifier of the invention.
Lanolin, main component are that sterols, fatty alcohols and triterpene alcohols and the fatty acid of about equivalent are generated
Ester, account for about 95%, also contain free alcohol 4%, and have a small amount of free fatty acid and hydrocarbons.Lanolin can allow skin
It is smooth tender.Water-in-oil emulsifier can be done, is excellent moistness substance.It can make to dry because lacking natural moisture or coarse
Dermalaxia and be restored.It is rather than moisture to be prevent completely to maintain the skin usual through epidermis by delay
Water content.Main ingredient can be made to be absorbed by mucous membrane and skin rapidly, there is adhesive force, property is stablized, and can absorb water, and is not easy rancid.Make
For one of emulsifier of the invention and water imbibition emulsifiable paste matrix.
Arabic gum, Arabic gum main component are high molecular polysaccharide and its calcium, magnesium and sylvite, mainly include natural gum
Aldose, galactolipin, glucuronic acid etc..Arabic gum has very good amphipathic property, is extraordinary natural oil-in-water
Type emulsion stabilizer;With good emulsification property, it is the hydrosol that purposes is wider in food industry, stabilizer can be made;Also have
There is the function of reducing Blood Cholesterol.As emulsifier and stabilizer of the invention.
Beeswax, sweet, tepor.Have inducing astrigency, sore, myogenic, analgesic, conditioning and other effects.Apply affected part, often make patent medicine excipients and
Ointment bases.Main ingredient has: the pure and mild carbohydrate of acids, free fatty acid, free-fat.In addition, there are also carotenoids
Element, vitamin A, aromatic substance etc..Beeswax has antibacterial and antisepsis.Paste sore myogenic pain relieving.Beeswax in the present invention is as cream
Agent, excipients and emulsifiable paste matrix.Also make myogenic pain relieving drug effect compatibility.
Rosa Damascana contains β-damascone (β-damascone), rose oxide (roseoxide), a- common perilla alkene.Flower also contains
Quercetin (quercetin), corn flower double glucoside (cyanin), organic acid, beta carotene (β-carotene), fat oils etc..
Rosa Damascana in the present invention is as aromatic.
The effect of Pu Rongshuan creams of the invention are as follows: (1) relieve pain dissipating bind;(2) prevention infection;(3) hemostasis and anti-inflammation;(4) it dissipates
Stagnation resolvation is swollen;(5) it prevents from festering;(6) face is hurt in healing of wound, reparation.
Compared with prior art, the invention has the following beneficial effects:
(1) prior art is all to carry out high temperature refinement using dry powder or drying sheet-shaped material, and raw material is in drying process
In, because of high-temperature process overlong time or period of storage is too long that original effective component is caused to be largely lost.It is of the present invention
Raw material is fresh raw material, including fresh dandelion, fresh cottonrose hibiscus leaf, fresh oldenlandia diffusa, fresh thin
Lotus leaf and fresh centella remain the effective component in raw material to greatest extent, prevent from causing because being dried to dry raw material
The loss of effective component, influences therapeutic effect;
(2) raw material of the invention is food grade raw material, reduces influence of the chemical industry steroids raw material to human body;Make ointment
Agent creams are safer, it is abundant to work;The adverse reaction for reducing drug allergy, expands the application range of crowd;
(3) the present invention overcomes the trouble of now-making-now-using in the prior art and perishable disadvantages, using modernization process
It is produced into finished product, it is ensured that make have convenience, long term guarantee quality storage, effect consistent.
(4) the smearing time is short, with other kinds of drugs as integrated the paste phases such as erythromycin ointment, Hibisci Paste used in wound
Than can significantly reduce administration time, shorten the course of disease, save spending, improve rehabilitation rate;Blister will not be played after painting, applied
With or so half an hour, so that it may clean, will not both delay working, will not influence to rest;It is clinical quick, it is long to reduce patient
Time insufferable pain;
(5) Pu Rongshuan creams of the invention have a wide range of application, and this product has for adult female's cyclomastopathy, mazoitis
Unsting, reduce swelling, cracked nipple of healing, anti-inflammatory, dissipating bind the effect of;General wound in surgery, such as: nail, bamboo and wood are stabbed, bruise
Damage, felon etc. all can be effective;It is to be applicable in more performances, the comprehensive medicament creams of multi-functional external application;
(6) simultaneous treatment of principal and subordinate symptoms.Pu Rongshuan creams of the invention are improved in technique, and fresh feed is effective by extracting
Ingredient is mutually compatible and is emulsified into the finished product of specification, and herbal medicine cream is allowed sufficiently to volatilize, permeate, simultaneous treatment of principal and subordinate symptoms in use, can be with
Collaboration doctor's advice takes taking for product orally.
In the present invention, each raw material component and its proportion are extremely crucial, after knowing above-mentioned each component and proportion, this field
Those of ordinary skill can be used various conventional traditional Chinese medicine extyaction methods and carry out effective component extracting, as decocting method, water mention
Alcohol deposition method, salting out method, organic solvent extraction etc. can obtain the main medicine in aforementioned Chinese medicine preparation due to said extracted method
Imitate ingredient, therefore can unsting, reduce swelling to mazoitis, dissipating bind have certain curative effect.
Wherein, organic solvent extraction are as follows: press one with the common solvents such as ethyl acetate, acetic acid, triethylamine and ethyl alcohol or water
After certainty ratio mixing, the specific effective component in medicinal material is targetedly extracted.It is extractable out by organic solvent extraction
The higher specific effective component of purity.
The method of the concentration includes but is not limited to: atmospheric evaporation, reduction vaporization, thin film evaporation, multiple-effect evaporation, purifying
Method includes but is not limited to: method of purification of saltouing, macroporous resin adsorption method of purification, ethanol precipitation method of purification, to change resin pure for ion effect
Change method, flocculation sedimentation method of purification, membrane separating and purifying method, polycaprolactam method of purification, silica gel absorption chromatographic purifying etc..
Dry method includes but is not limited to: oven drying method, drum-type seasoning, belt drying method, hygroscopic desiccation method, boiling are dry
Dry method, spray drying process, hypobaric drying method, freeze-drying, infrared drying, micro-wave drying method etc..
Specific embodiment
To make the object, technical solutions and advantages of the present invention clearer, technical solution of the present invention will be carried out below
Detailed description.Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Base
Embodiment in the present invention, those of ordinary skill in the art are obtained all without making creative work
Other embodiment belongs to the range that the present invention is protected.
Embodiment 1
A kind of Pu Rongshuan creams are present embodiments provided, are prepared by following raw material: dandelion 14kg;Cottonrose hibiscus leaf 10kg;
Oldenlandia diffusa 8kg;Dried peppermint leaf 4kg;Centella 4kg and Rosmarinic acid 0.8kg.
Preparation method, comprising the following steps:
(1) it is cut after fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella being removed impurity respectively
It is broken, it is mixed to form mixture, the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, pure water is added and is mentioned
It takes, forms extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by macroreticular resin, then is washed using ethyl alcohol
It is de-, obtain refined solution;
(3) refined solution that step (2) obtains is evaporated concentration, obtained and mixture etc. described in step (1)
The medicinal extract extracting solution of weight;
(4) after addition Rosmarinic acid is mixed into the medicinal extract extracting solution that step (3) obtains, pure water is added,
It is steam heated to 75-85 DEG C after mixing, is added in substrate material and is uniformly mixed, Rosa Damascana is then added, is uniformly mixed,
It is cooled into liquid lotion;Substrate material is mixed by weight for 1:1 by beeswax and grape seed oil;
(5) the liquid lotion for obtaining step (4) emulsifies, then carries out being ground to fine-micron level degree, sterilizing
Afterwards up to the Pu Rongshuan creams.
Embodiment 2
A kind of Pu Rongshuan creams are present embodiments provided, are prepared by following raw material:
Dandelion 16kg;Cottonrose hibiscus leaf 8kg;Oldenlandia diffusa 10kg;Dried peppermint leaf 5kg;Centella 3kg;Rosmarinic acid
1.0kg;Camellia oil 1kg;Beeswax 9kg;Lanolin 4.0kg;Arabic gum 4.5kg.
Preparation method, comprising the following steps:
(1) fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are weighed, fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and the total amount of adding of centella be finished weight 40%, by fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are shredded after removing impurity respectively, are mixed to form mixture, are put into pure
Water did not had mixture 2cm, and the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, and pure water is added and is uniformly mixed,
The total amount of adding of pure water and the weight ratio of mixture are 240:40, extract 1 hour at 60 DEG C, form extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by LSA-21 macroreticular resin, then uses food grade
Ethyl alcohol is eluted, and refined solution is obtained;
(3) refined solution that step (2) obtains is evaporated at 100 DEG C concentration 120 minutes, obtained and step
(1) the medicinal extract extracting solution of the weight such as the mixture described in;
(4) weigh substrate material according to the ratio, the total amount of adding of substrate material is the 18% of finished weight, including camellia oil, beeswax,
Lanolin and Arabic gum are steam heated to 110 DEG C after mixing, substrate material is completely dissolved fusion, are subsequently cooled to 75 DEG C, filtering
Constant temperature is kept spare afterwards;After into the medicinal extract extracting solution that step (3) obtains, addition Rosmarinic acid is mixed, it is added pure
Water is steam heated to 75 DEG C after mixing, is added in substrate material and carries out being thoroughly mixed 40 for 80 revs/min by revolving speed
Minute, Rosa Damascana is then added, continues stirring 1 hour until being uniformly mixed, is cooled into liquid lotion;
(5) the liquid lotion for obtaining step (4) emulsifies, then, first that the liquid lotion is thin by 200 mesh
Granularity is ground, then divides 5 circulating reflux millizations;260 mesh fine granularities finally are arranged in colloidal mill, all cremes are ground, most
Afterwards, using ultraviolet disinfection 4 hours, then ozone sterilization is passed through 8 hours to get the Pu Rongshuan creams, to the refreshing cream of the Pu Rong
It is aseptic subpackaged by clean automatic air pressure filling machine progress that frost standing is placed on the workshop GMP for 24 hours.
Embodiment 3
A kind of Pu Rongshuan creams are present embodiments provided, are prepared by following raw material:
Dandelion 12kg;Cottonrose hibiscus leaf 12kg;Oldenlandia diffusa 6kg;Dried peppermint leaf 3kg;Centella 5kg;Rosmarinic acid
0.6kg;Camellia oil 3kg;Beeswax 6kg;Lanolin 4.5kg;Arabic gum 4.0kg.
Preparation method, comprising the following steps:
(1) fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are weighed, fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and the total amount of adding of centella be finished weight 40%, by fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are shredded after removing impurity respectively, are mixed to form mixture, are put into pure
Water did not had mixture 1cm, and the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, and pure water is added and is uniformly mixed,
The total amount of adding of pure water and the weight ratio of mixture are 240:40, extract 1 hour at 60 DEG C, form extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by LSA-21 macroreticular resin, then uses food grade
Ethyl alcohol is eluted, and refined solution is obtained;
(3) refined solution that step (2) obtains is evaporated at 100 DEG C concentration 120 minutes, obtained and step
(1) the medicinal extract extracting solution of the weight such as the mixture described in;
(4) weigh substrate material according to the ratio, the total amount of adding of substrate material is the 18% of finished weight, including camellia oil, beeswax,
Lanolin and Arabic gum are steam heated to 110 DEG C after mixing, substrate material is completely dissolved fusion, are subsequently cooled to 85 DEG C, filtering
Constant temperature is kept spare afterwards;After into the medicinal extract extracting solution that step (3) obtains, addition Rosmarinic acid is mixed, it is added pure
Water is steam heated to 85 DEG C after mixing, is added in substrate material and carries out being thoroughly mixed 40 for 80 revs/min by revolving speed
Minute, Rosa Damascana is then added, continues stirring 1 hour until being uniformly mixed, is cooled into liquid lotion;
(5) the liquid lotion for obtaining step (4) emulsifies, then, first that the liquid lotion is thin by 200 mesh
Granularity is ground, then divides 5 circulating reflux millizations;260 mesh fine granularities finally are arranged in colloidal mill, all cremes are ground, most
Afterwards, using ultraviolet disinfection 4 hours, then ozone sterilization is passed through 8 hours to get the Pu Rongshuan creams, to the refreshing cream of the Pu Rong
It is aseptic subpackaged by clean automatic air pressure filling machine progress that frost standing is placed on the workshop GMP for 24 hours.
Embodiment 4
A kind of Pu Rongshuan creams are present embodiments provided, are prepared by following raw material:
Dandelion 14kg;Cottonrose hibiscus leaf 10kg;Oldenlandia diffusa 8kg;Dried peppermint leaf 4kg;Centella 4kg;Rosmarinic acid
0.8kg;Camellia oil 2kg;Beeswax 7.5kg;Lanolin 4.25kg;Arabic gum 4.25kg.
Preparation method, comprising the following steps:
(1) fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are weighed, fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and the total amount of adding of centella be finished weight 40%, by fresh dandelion,
Cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella are shredded after removing impurity respectively, are mixed to form mixture, are put into pure
Water did not had mixture 2cm, and the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, and pure water is added and is uniformly mixed,
The total amount of adding of pure water and the weight ratio of mixture are 240:40, extract 1 hour at 60 DEG C, form extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by LSA-21 macroreticular resin, then uses food grade
Ethyl alcohol is eluted, and refined solution is obtained;
(3) refined solution that step (2) obtains is evaporated at 100 DEG C concentration 120 minutes, obtained and step
(1) the medicinal extract extracting solution of the weight such as the mixture described in;
(4) weigh substrate material according to the ratio, the total amount of adding of substrate material is the 18% of finished weight, including camellia oil, beeswax,
Lanolin and Arabic gum are steam heated to 110 DEG C after mixing, substrate material is completely dissolved fusion, are subsequently cooled to 80 DEG C, filtering
Constant temperature is kept spare afterwards;After into the medicinal extract extracting solution that step (3) obtains, addition Rosmarinic acid is mixed, it is added pure
Water is steam heated to 80 DEG C after mixing, is added in substrate material and carries out being thoroughly mixed 40 for 80 revs/min by revolving speed
Minute, Rosa Damascana is then added, continues stirring 1 hour until being uniformly mixed, is cooled into liquid lotion;
(5) the liquid lotion for obtaining step (4) emulsifies, then, first that the liquid lotion is thin by 200 mesh
Granularity is ground, then divides 5 circulating reflux millizations;260 mesh fine granularities finally are arranged in colloidal mill, all cremes are ground, most
Afterwards, using ultraviolet disinfection 4 hours, then ozone sterilization is passed through 8 hours to get the Pu Rongshuan creams, to the refreshing cream of the Pu Rong
It is aseptic subpackaged by clean automatic air pressure filling machine progress that frost standing is placed on the workshop GMP for 24 hours.
The application method of Pu Rongshuan creams of the invention is applied 2 times a day according to affected part size and is smeared, and thickness is no more than
The Pu Rongshuan creams of the invention of 0.5mm clean after each chrisma creams half an hour.
The content of effective component is more in Pu Rongshuan creams provided by the invention, has preferably treatment mazoitis and cream
The effect of gland hyperplasia;It can be with strengthen immunity.It is found in follow-up follow-up observation, treatment silver bits of the invention provided by the invention
The Chinese medicine composition of disease is day using the time, applies smear Pu Rongshuan creams of the invention 2 times a day, each topical application of drug half an hour, have
The preferably effect for the treatment of psoriasis.
Original formulation of the invention is family's ointment secret recipe of place treatment mammary gland and skin disease, in Guangdong province, China Chaozhou-Shantou region
Now green grass ointment processed is applied to medicinal for the regional long-term external application as treatment mazoitis and scytitis;Improved cost hair
Bright Pu Rongshuan emulsifiable paste, it is prefabricated to be packaged into emulsification ointment, and by Chaozhou Zhu Yangtang health-care room, Tian Chuan vocational school, time of childbirth club, the moon
Health hall stimulating milk secretion teacher services Dian Dengge service unit and starts tissue to having the proliferation of mammary gland and other mammitis, skin in 2018.3.12
Skin inflammation is carried out 3 months efficacy validations by object is treated;It is applied 2 times a day according to affected part size and smears the refreshing cream of Pu Rong of the invention
Frost cleans after each chrisma creams half an hour;Through counting:
(1) lactation mastitis disease is by treating 61 people of object, and 40 are relieved pain by treating object and reach for application 2 times on day 1
Knot effect is changed in swelling;13 are reached detumescenceization knot effect of unstinging by object is treated on day 2, and 7 are reached on day 3 by object is treated
The effect of detumescenceization of unstinging knot;1 by treating, object was relieved pain at first 3 days, agglomerating does not dissipate.
(2) cyclomastopathy female patient is by treating object 57, and the application before official holiday monthly, 35 by treatment object first
It is relieved pain, softening is agglomerated, 14 by treat second day pain of object disappear, smallization of agglomerating, 6 by treating object third day pain
It disappears bitterly, smallization of agglomerating.2 by treat object first three days reach relieve pain to pain disappear, unobvious smallization of agglomeration.
(3) stab, bruise turn round bruise, felon, cracked nipple patient by treat object 22;There are stasis of blood the wounded 9,
All reach within one day anti-inflammatory analgesic, the effect of quick stagnation resolvation;There are laceration of skin purulence inflammation person 13 discharges of first day wound stasis of blood purulence, healings
Incrustation, third day wound start decrustation myogenic.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any
Those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, and should all contain
Lid is within protection scope of the present invention.Therefore, protection scope of the present invention should be based on the protection scope of the described claims.
Claims (10)
1. a kind of Pu Rongshuan creams, which is characterized in that the Pu Rongshuan creams are prepared by following raw material, and the raw material is by weight
It include: 12-16 parts of dandelion;8-12 parts of cottonrose hibiscus leaf;6-10 parts of oldenlandia diffusa;3-5 parts of dried peppermint leaf;3-5 parts of centella and
0.6-1.0 parts of Rosmarinic acid.
2. Pu Rongshuan creams according to claim 1, which is characterized in that the raw material includes by camellia oil, beeswax, wool
The substrate material of rouge and Arabic gum composition, the substrate material includes: 1-3 parts of camellia oil by weight;6-9 parts of beeswax;Lanolin
4.0-4.5 part;4.0-4.5 parts of Arabic gum.
3. Pu Rongshuan creams according to claim 2, which is characterized in that the Pu Rongshuan creams are prepared by following raw material,
The raw material includes: 14 parts of dandelion by weight;10 parts of cottonrose hibiscus leaf;8 parts of oldenlandia diffusa;4 parts of dried peppermint leaf;Centella 4
Part;0.8 part of Rosmarinic acid;2 parts of camellia oil;7.5 parts of beeswax;4.25 parts of lanolin;4.25 parts of Arabic gum.
4. the method for preparing any Pu Rongshuan creams of claim 1-3, which is characterized in that the method includes following steps
It is rapid:
(1) it shreds, mixes after fresh dandelion, cottonrose hibiscus leaf, oldenlandia diffusa, dried peppermint leaf and centella being removed impurity respectively
Conjunction forms mixture, and the mixture is put into continuous flow upstream ultrasonic and circulated extraction device, and pure water is added and extracts, is formed
Extracting solution;
(2) first the extracting solution that step (1) obtains is adsorbed by macroreticular resin, then is eluted using ethyl alcohol, obtained
To refined solution;
(3) refined solution that step (2) obtains is evaporated concentration, obtained and the weight such as mixture described in step (1)
Medicinal extract extracting solution;
(4) after addition Rosmarinic acid is mixed into the medicinal extract extracting solution that step (3) obtains, pure water, mixing is added
It is steam heated to 75-85 DEG C after uniformly, is added in substrate material and is uniformly mixed, Rosa Damascana is then added, is uniformly mixed, it is cooling
Form liquid lotion;
(5) the liquid lotion for obtaining step (4) emulsifies, then carries out being ground to fine-micron level degree, after sterilizing i.e.
Obtain the Pu Rongshuan creams.
5. the preparation method of Pu Rongshuan creams according to claim 4, which is characterized in that in step (4), the substrate material
The preparation method comprises the following steps: weigh camellia oil, beeswax, lanolin and Arabic gum according to the ratio, be steam heated to and be completely dissolved after mixing
Fusion, is subsequently cooled to 75-85 DEG C, constant temperature is spare after filtering.
6. the preparation method of Pu Rongshuan creams according to claim 5, which is characterized in that it is described to be steam heated to 110 DEG C,
Substrate material is completely dissolved fusion, is subsequently cooled to 80 DEG C, and constant temperature is spare at 80 DEG C after filtering.
7. the preparation method of Pu Rongshuan creams according to claim 4, which is characterized in that in step (1), the mixture
Total amount of adding be the Pu Rongshuan creams weight 40%;In step (4), the total amount of adding of the substrate material is the Pu Rong
The 18% of refreshing creams weight.
8. the preparation method of Pu Rongshuan creams according to claim 4, which is characterized in that in step (1), before the extraction
Pure water is first added and did not had mixture 1-2cm, impregnates 30 minutes, the mixture is then put into continuous flow upstream ultrasonic circulation and is mentioned
It takes in device, adds pure water and extract;The total amount of adding of the pure water and the weight ratio of mixture are 240:40;Institute
The temperature for stating extraction is 60 DEG C, and the time of the extraction is 1 hour.
9. the preparation method of Pu Rongshuan creams according to claim 4, which is characterized in that in step (2), the macropore tree
Rouge is LSA-21 macroreticular resin, and the ethyl alcohol is food grade ethyl alcohol.
10. the preparation method of Pu Rongshuan creams according to claim 4, which is characterized in that in step (3), the evaporation
The temperature of concentration is 100 DEG C, and the time of the evaporation and concentration is 120 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811552156.5A CN109394869A (en) | 2018-12-18 | 2018-12-18 | Pu Rongshuan creams and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811552156.5A CN109394869A (en) | 2018-12-18 | 2018-12-18 | Pu Rongshuan creams and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109394869A true CN109394869A (en) | 2019-03-01 |
Family
ID=65459874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811552156.5A Pending CN109394869A (en) | 2018-12-18 | 2018-12-18 | Pu Rongshuan creams and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109394869A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116549575A (en) * | 2023-02-09 | 2023-08-08 | 天津市武清区爱康中医医院 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1134831A (en) * | 1995-06-06 | 1996-11-06 | 谭少奇 | Composite pharmaceutics made of oldenlandia and usage thereof |
CN103599187A (en) * | 2013-11-01 | 2014-02-26 | 西安医学院 | Chinese herbal medicine for treating mastitis of dairy cow and nanometer injection preparation method of Chinese herbal medicine |
-
2018
- 2018-12-18 CN CN201811552156.5A patent/CN109394869A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1134831A (en) * | 1995-06-06 | 1996-11-06 | 谭少奇 | Composite pharmaceutics made of oldenlandia and usage thereof |
CN103599187A (en) * | 2013-11-01 | 2014-02-26 | 西安医学院 | Chinese herbal medicine for treating mastitis of dairy cow and nanometer injection preparation method of Chinese herbal medicine |
Non-Patent Citations (2)
Title |
---|
浙江省《西医学习中医试用教材》编写组: "《中医临床学》", 31 August 1978, 杭州:浙江人民出版社 * |
肖国士等: "《中医秘方全书》", 30 June 2012, 长沙:湖南科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116549575A (en) * | 2023-02-09 | 2023-08-08 | 天津市武清区爱康中医医院 | Traditional Chinese medicine composition for treating hyperplasia of mammary glands and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5646117B2 (en) | Hair growth promoter and production method | |
CN105125466A (en) | Freckle removing night cream and preparing method thereof | |
CN105193693A (en) | Pore refining cream containing deep-sea essence and preparation method of cream | |
CN105288597B (en) | A kind of drug for treating cutaneous pigmentation | |
CN103316146A (en) | Traditional Chinese medicinal preparation for anesthesia | |
CN105326753A (en) | Cheilogramma-fading nourishing lipstick and preparing method thereof | |
CN113133957A (en) | Plant fermentation lifting compact anti-oxidation anti-fatigue eye mask and preparation method thereof | |
WO2015018124A1 (en) | Traditional chinese medicine preparation for reducing blood pressure and preparation method thereof | |
CN105125467A (en) | Emulsion removing red blood and preparing method of emulsion | |
CN103933405A (en) | Pharmaceutical composition for treating qi-blood deficiency burn, and preparation method thereof | |
CN109394869A (en) | Pu Rongshuan creams and preparation method thereof | |
CN115518127A (en) | Antibacterial, anti-inflammatory, detumescence and itching relieving cream and preparation method thereof | |
CN108721592A (en) | It is a kind of to be used to treat essential oil of shoulder and neck and preparation method thereof | |
CN102764345A (en) | Basil-bluegum ointment for curing burns and preparation method thereof | |
CN105902690A (en) | Traditional Chinese medicine soap applied to rheumatic arthritis | |
CN106334176B (en) | Chilblain ointment capable of relieving swelling, pain and itching and preparation method thereof | |
CN104623304A (en) | Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion | |
CN111544523A (en) | Traditional Chinese medicine composition for treating skin ulceration and application thereof | |
CN105920379A (en) | Traditional Chinese medicine eye cream to alleviate pouch and preparation method thereof | |
CN105919907A (en) | Manufacturing method of traditional Chinese medicine eye cream and eye cream | |
CN105168091A (en) | Telangiectasis removing mask powder and preparation method thereof | |
CN110812377A (en) | Acne treatment and repair composition and application thereof | |
CN104623040A (en) | Nursing composition with wound sterilization and inflammation diminishment effects and preparation method thereof | |
CN105106085A (en) | Chinese medicinal herb sunscreen cream containing attapulgite | |
CN104547758A (en) | Medicine for treating qi-deficiency and blood-stasis type keloid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190301 |
|
RJ01 | Rejection of invention patent application after publication |